Journal article
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury
Abstract
BACKGROUND AND OBJECTIVES: The risk-benefit ratio of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after AKI may be altered due to concerns regarding recurrent AKI. We evaluated, in a prospective cohort, the association between use (versus nonuse) of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and the subsequent risk of AKI and other adverse outcomes after hospitalizations with and …
Authors
Brar S; Liu KD; Go AS; Hsu RK; Chinchilli VM; Coca SG; Garg AX; Himmelfarb J; Ikizler TA; Kaufman J
Journal
Clinical Journal of the American Society of Nephrology, Vol. 16, No. 1, pp. 26–36
Publisher
Wolters Kluwer
Publication Date
January 2021
DOI
10.2215/cjn.10840720
ISSN
1555-9041
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute Kidney InjuryAgedAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsDisease ProgressionFemaleHeart FailureHospitalizationHumansKidney DiseasesMaleMiddle AgedMortalityProportional Hazards ModelsProspective StudiesRecurrenceRenin-Angiotensin SystemRisk AssessmentRisk Factors